Patents by Inventor Roger S. -C. Chen

Roger S. -C. Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Phenethylsulfone isoindoline derivatives and their use
    Patent number: 8853175
    Abstract: Provided are phenethyl isoindoline compounds, and pharmaceutically acceptable salts, solvates, or stereoisomers thereof. Methods of use and pharmaceutical compositions of these compounds are also disclosed.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: October 7, 2014
    Assignee: Celgene Corporation
    Inventors: Gondi Kumar, Hon-Wah Man, Roger S. C. Chen, George W. Muller, Anthony J. Frank
  • PHENETHYLSULFONE ISOINDOLINE DERIVATIVES AND THEIR USE
    Publication number: 20120178708
    Abstract: Provided are phenethyl isoindoline compounds, and pharmaceutically acceptable salts, solvates, or stereoisomers thereof. Methods of use and pharmaceutical compositions of these compounds are also disclosed.
    Type: Application
    Filed: January 9, 2012
    Publication date: July 12, 2012
    Applicant: Celgene Corporation
    Inventors: Gondi KUMAR, Hon-Wah Man, Roger S.C. Chen, George W. Muller, Anthony J. Frank
  • THIOXOISOINDOLINE COMPOUNDS AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME
    Publication number: 20090298882
    Abstract: Provided are thioxo isoindoline compounds, and pharmaceutically acceptable salts, solvates, and stereoisomers, thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.
    Type: Application
    Filed: May 13, 2009
    Publication date: December 3, 2009
    Inventors: George W. Muller, Roger S.C. Chen
  • Method of reducing TNF.alpha. levels with amino substituted 2-(2,6-dioxopiperidin-3-yl)-1-oxo-and 1,3-dioxoisoindolines
    Patent number: 5635517
    Abstract: 1-Oxo- and 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl) isoindolines substituted with amino in the benzo ring reduce the levels of TNF.alpha. in a mammal. A typical embodiment is 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline.
    Type: Grant
    Filed: July 24, 1996
    Date of Patent: June 3, 1997
    Assignee: Celgene Corporation
    Inventors: George W. Muller, David I. Stirling, Roger S. -C. Chen